Stockreport

Radius Health Initiates Phase 3 Clinical Trial of Abaloparatide Injection for the Treatment of Male Osteoporosis

Radius Recycling, Inc. - Class A  (RDUS) 
Last radius recycling, inc. - class a earnings: 2/27 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: investors.radiuspharm.com
PDF WALTHAM, Mass., March 30, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq:RDUS) announced today that the company has initiated the Phase 3 ATOM (Abaloparatide Tre [Read more]